A novel functional translocator protein ligand for cancer imaging

Mingfeng Bai1, Malena B Rone, Vassilios Papadopoulos

  • 1Department of Chemistry, Vanderbilt University, VU Station B 351822, Nashville, TN 37235-1822, USA.

Bioconjugate Chemistry
|November 6, 2007
PubMed

Insights

Researchers developed new molecular imaging agents targeting the translocator protein (TSPO), which is upregulated in many cancers. These novel ligands, n-TSPOmbb732, show promise for in vitro tumor imaging applications.

Area of Science:

  • Biochemistry
  • Molecular Imaging
  • Oncology

Background:

  • The translocator protein (TSPO) is frequently overexpressed in various cancer types.
  • TSPO is a promising molecular target for cancer detection and diagnosis.

Purpose of the Study:

  • To develop novel functional ligands for TSPO-targeted molecular imaging.
  • To evaluate the applicability of these ligands in cancer imaging.

Main Methods:

  • Synthesis of a series of functional TSPO ligands (n-TSPOmbb732).
  • Conjugation of signaling moieties to the ligands.
  • In vitro binding affinity assays.
  • Fluorescent imaging studies.

Main Results:

  • The developed n-TSPOmbb732 ligands are widely applicable for TSPO-targeted molecular imaging.
  • Two fluorescent dye-labeled 6-TSPOmbb732 derivatives exhibited nanomolar binding affinities to TSPO.
  • Successful in vitro imaging of TSPO-expressing cells was achieved.

Conclusions:

  • The novel n-TSPOmbb732 ligands are effective for TSPO-targeted molecular imaging.
  • These ligands demonstrate potential for in vitro cancer imaging applications.

Related Concept Videos